- Home
- CBIO vs MAMA Comparison
CBIO vs MAMA Comparison
Compare CBIO & MAMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBIO
- MAMA
- Stock Information
- Founded
- CBIO 2003
- MAMA 2010
- Country
- CBIO United States
- MAMA United States
- Employees
- CBIO N/A
- MAMA N/A
- Industry
- CBIO
- MAMA Specialty Foods
- Sector
- CBIO
- MAMA Consumer Staples
- Exchange
- CBIO Nasdaq
- MAMA Nasdaq
- Market Cap
- CBIO 308.0M
- MAMA 323.1M
- IPO Year
- CBIO N/A
- MAMA N/A
- Fundamental
- Price
- CBIO $14.29
- MAMA $7.98
- Analyst Decision
- CBIO Strong Buy
- MAMA Strong Buy
- Analyst Count
- CBIO 5
- MAMA 3
- Target Price
- CBIO $25.60
- MAMA $10.33
- AVG Volume (30 Days)
- CBIO 98.3K
- MAMA 154.7K
- Earning Date
- CBIO 07-31-2025
- MAMA 09-08-2025
- Dividend Yield
- CBIO N/A
- MAMA N/A
- EPS Growth
- CBIO N/A
- MAMA N/A
- EPS
- CBIO N/A
- MAMA 0.11
- Revenue
- CBIO N/A
- MAMA $128,745,000.00
- Revenue This Year
- CBIO N/A
- MAMA $17.24
- Revenue Next Year
- CBIO N/A
- MAMA $9.95
- P/E Ratio
- CBIO N/A
- MAMA $72.57
- Revenue Growth
- CBIO N/A
- MAMA 17.04
- 52 Week Low
- CBIO $10.83
- MAMA $5.50
- 52 Week High
- CBIO $21.40
- MAMA $9.98
- Technical
- Relative Strength Index (RSI)
- CBIO 52.92
- MAMA 41.43
- Support Level
- CBIO $13.50
- MAMA $8.37
- Resistance Level
- CBIO $16.00
- MAMA $8.74
- Average True Range (ATR)
- CBIO 0.79
- MAMA 0.31
- MACD
- CBIO 0.16
- MAMA -0.00
- Stochastic Oscillator
- CBIO 39.68
- MAMA 10.11
About CBIO Crescent Biopharma Inc. Common Stock
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.